Serosurvey for polio antibodies

Area of Science:

• * Virology and Immunology
• * Public Health and Epidemiology

Background:

• * Poliomyelitis remains a significant public health concern, necessitating ongoing monitoring of population immunity.
• * Understanding polio immunity levels is crucial for assessing the effectiveness of vaccination campaigns and informing public health strategies.

Purpose of the Study:

• * To evaluate the population's polio immunity status by measuring neutralizing antibodies against poliovirus types 1, 2, and 3.
• * To compare immunity levels across different age groups and vaccination histories.

Main Methods:

• * A serological survey conducted from 1982 to 1988 involving 573 participants aged 3-80 years.
• * Neutralizing antibody testing against Sabin vaccine strains (types 1, 2, 3) and a wild poliovirus type 1 strain.
• * Participants categorized into four groups based on birth date, vaccination history, and potential exposure to past polio epidemics.

Main Results:

• * High seropositivity rates observed across all groups: 96.7%-98.9% for type 2, 91.8%-98.2% for type 1 (Sabin), 89.3%-96.6% for type 3, and 84.2%-96.4% for type 1 (wild).
• * Highest immunity levels were found in fully vaccinated children (Group D) and unvaccinated individuals contemporary to past polio epidemics (Group A).
• * A notable finding included 14 subjects with adequate antibodies against Sabin strains but seronegative for wild type 1 poliovirus.

Conclusions:

• * The surveyed population demonstrated a satisfactory level of polio immunity, indicating the success of vaccination programs and/or natural exposure.
• * The study highlights the importance of considering both vaccination history and potential exposure when assessing population immunity.
• * Further investigation is warranted for individuals with discordant antibody responses to vaccine and wild poliovirus strains.